Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice

Tumor necrosis factor-α (TNF-α) inhibitors are increasingly becoming the standard of care for treating a number of inflammatory diseases. However, treatment with TNF-α inhibitors carries an inherent risk of compromising the immune system, resulting in an increased susceptibility to infections and ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi-Hsing, de Carvalho, Hellen MDS, Kalyoncu, Umut, Llamado, Lyndon John Q, Solano, Gaston, Pedersen, Ron, Lukina, Galina, Lichauco, Juan J, Vasilescu, Radu S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769557/
https://www.ncbi.nlm.nih.gov/pubmed/29391775
http://dx.doi.org/10.2147/BTT.S148606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769557/
https://www.ncbi.nlm.nih.gov/pubmed/29391775
http://dx.doi.org/10.2147/BTT.S148606

Ejemplares similares